Prof. Dr. Hans-Peter Zenner

Education. M.D. University of Mainz, Germany; Studies in Paris, France; Dr. med. in oncological research; BBA and MBA in Zurich (Switzerland) and Koblenz (Germany).

Professional Carreer. CEO Digitineers GmbH&CoKG, Tübingen, Germany; Distinguished Professor, Chair and Medical Director University Hospital Tü­bingen, Germany; Post-Doc Dept. of Biochemistry, University of Würzburg, Germany.

Honorary Offices. 2009 and 2010 President German Association of Physicians and Scientists (GDNÄ); 2010-2021 Board Member, German Natl. Acad. Sci. Leopoldina.

Awards. Various awards including Leibniz Prize, Humboldt Medalist. Several Inter­national Memberships of Honor and several Doctorates honoris causa.

Research and Development Focus.  Medical De­vices including the Tübingen Titanium Prostheses (TTP), totally implantable implants, cochlear implant technol­ogy; Digital Health Technology; Anti cancer monoclonal AB technology.

Start ups. Sound Pharmaceuticals (SPI), Seattle, WA, USA; Vibrosonic GmbH, Mannheim, Germany; Digitineers GmbH, Tübingen.